Table III.

Association of miR-34a and Ki67 with the clinicopathological features in patients with NPC.

Clinicopathological features	n	miR-34a (n=56)	t value	P-value	Ki67 (n=56)	t value	P-value
Age (years)			0.302	0.764		0.196	0.846
<50	27	4.804±0.212			8.037±0.368
≥50	29	4.787±0.209			8.018±0.359
Sex			0.462	0.646		0.662	0.511
Male	41	4.675±0.221			7.856±0.372
Female	15	4.706±0.226			7.784±0.326
Smoking history			1.627	0.110		0.063	0.950
Yes	25	4.497±0.217			8.022±0.418
No	31	4.616±0.224			8.015±0.415
Differentiation			0.898	0.373		0.171	0.866
Undifferentiated	14	4.772±0.236			7.982±0.387
Low and moderately differentiated	42	4.844±0.267			8.003±0.403
Bone metastasis			9.020	<0.001		0.069	0.945
Yes	19	4.334±0.202			8.029±0.417
No	37	4.947±0.258			8.021±0.408
Lymphatic metastasis			0.708	0.482		8.951	<0.001
Yes	18	4.578±0.225			7.847±0.384
No	38	4.624±0.228			6.984±0.313
Local invasion of tumor			0.725	0.472		0.926	0.359
Yes	24	4.734±0.243			7.815±0.357
No	32	4.782±0.247			7.729±0.334
TNM staging			10.110	<0.001		20.535	<0.001
Stage I–II	33	4.884±0.236			6.324±0.305
Stage III–IV	23	4.263±0.211			8.293±0.413

NPC, nasopharyngeal carcinoma.